HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

August 2021

Recent Breakthroughs in the Treatment of Alzheimer Disease

August 23, 2021

NeurologyLive Peer Exchange

This NeurologyLive® Peers & Perspectives series features experts in the diagnosis and treatment of Alzheimer disease discussing the recent approval of aducanumab, its implications for Alzheimer disease, and other promising therapies and diagnostic technologies in development.

BTK Inhibitor Fenebrutinib Aims to Tackle Progressive MS in FENtrepid Trial

August 20, 2021

Clinical Trial Focus

The agent’s safety profile has been studied in more than 1200 individuals to date across several inflammatory diseases, with data indicating that the high selectivity of fenebrutinib may limit off-target effects.

It Is Time to Redefine Outcomes in Pediatric Epilepsy Surgery

August 16, 2021

Letter From the Editor

Successful epilepsy surgery in adults has been followed by forced normalization, depression, and memory issues, resulting in questions about the use of the metrics in the study of broader outcomes—a problem even more prominent in pediatric epilepsy surgery.

FDA Commissioner Calls for Independent Review of Agency Interactions on Aducanumab

July 09, 2021

In the Headlines

Janet Woodcock, MD, acting commissioner of the FDA, called for an inquiry by the Office of the Inspector General into possible interactions between agency officials and Biogen that "may have occurred outside of the formal correspondence process."

Questions Linger Around COVID-19’s Origin

June 24, 2021

Chairman's Letter

Mike Hennessy Sr, Chairman and founder, MJH Life Sciences™, offers his perspective on the questions around the origin of COVID-19 and applauds the extensive efforts to produce vaccines.

MRI in Multiple Sclerosis Guidelines Update: North America, Europe Align on New Recommendations

June 15, 2021

In the Headlines

These consensus guidelines are significant not only for their key updates to clinical practice but for their representation of a more unified, global approach to diagnosing and monitoring patients with multiple sclerosis.